2017
DOI: 10.1021/jacs.6b11382
|View full text |Cite
|
Sign up to set email alerts
|

Biological Photothermal Nanodots Based on Self-Assembly of Peptide–Porphyrin Conjugates for Antitumor Therapy

Abstract: Photothermal agents can harvest light energy and convert it into heat, offering a targeted and remote-controlled way to destroy carcinomatous cells and tissues. Inspired by the biological organization of polypeptides and porphyrins in living systems, here we have developed a supramolecular strategy to fabricate photothermal nanodots through peptide-modulated self-assembly of photoactive porphyrins. The self-assembling nature of porphyrins induces the formation of J-aggregates as substructures of the nanodots, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

11
557
2
6

Year Published

2017
2017
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 800 publications
(592 citation statements)
references
References 49 publications
(65 reference statements)
11
557
2
6
Order By: Relevance
“…Compared to other conventional therapeutic techniques, PTT boasts many merits such as the simplicity, minimal invasiveness, low incidence of complications, as well as the high spatial and temporal precision of NIR light 8, 9, 10, 11. Various types of nanoagents have been explored to attain better PTT performance12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 and in the treatment, intravenous injection of the nanoagents (to mice, for example) is followed by high‐power NIR laser irradiation for ablation 25, 26, 27, 28, 29. Despite recent progress, clinical adoption of PTT still faces several hurdles.…”
Section: Introductionmentioning
confidence: 99%
“…Compared to other conventional therapeutic techniques, PTT boasts many merits such as the simplicity, minimal invasiveness, low incidence of complications, as well as the high spatial and temporal precision of NIR light 8, 9, 10, 11. Various types of nanoagents have been explored to attain better PTT performance12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 and in the treatment, intravenous injection of the nanoagents (to mice, for example) is followed by high‐power NIR laser irradiation for ablation 25, 26, 27, 28, 29. Despite recent progress, clinical adoption of PTT still faces several hurdles.…”
Section: Introductionmentioning
confidence: 99%
“…[8] While organic PTAs were intended to reduce concerns relevant to inorganic PTAs, most of them are still subject to various limitations including complicated fabrication, indistinct degradation, and potential biosafety concerns. [9] Therefore, the development of novel NMs-based PTAs is of vital significance and clinical value.…”
mentioning
confidence: 99%
“…[29,30] In recent years, excip ientfree nanomedicines have attracted extensive attention for highly efficient dug delivery. [38][39][40] To this end, we herein reported a robust approach, so called indocyanine green (ICG)templated selfassembly strategy for preparing twoinone nanomedicine and combination immuno therapy. [35][36][37] Chemical modification of the small molecular therapeutics are essential for developing conventional excipientfree nanoparticles, which might impair the therapeutic performance of the anticancer drugs.…”
mentioning
confidence: 99%